Added to YB: 2017-10-03
Pitch date: 2017-10-03
HEPA:US [bullish]
Hepion Pharmaceuticals, Inc.
-100%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Hepion Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatment for hepatocellular carcinoma (HCC), metabolic liver diseases, and chronic liver diseases in the United States.
Market Cap
$2.8M
Pitch Price
$207.2K
Price Target
N/A
Dividend
N/A
EV/EBITDA
N/A
P/E
-0.37
EV/Sales
N/A
Sector
Pharmaceuticals
Category
N/A
Show full summary:
Hepion Pharmaceuticals, Inc. HEPA:US
A summary for this pitch has not been created yet.
Read full article (0 min)